Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Lymphoid 1

Conditions

Lymphoma 341Precursor Cell Lymphoblastic Leukemia-Lymphoma 264Leukemia, Lymphocytic, Chronic, B-Cell 249Lymphoma, Non-Hodgkin 227Lymphoma, Large B-Cell, Diffuse 208Lymphoma, Follicular 201Burkitt Lymphoma 183Lymphoma, Mantle-Cell 166Leukemia 148Lymphoma, B-Cell, Marginal Zone 145Hodgkin Disease 141Lymphoma, Large-Cell, Immunoblastic 124Lymphoma, T-Cell, Cutaneous 108Leukemia, Myeloid, Acute 106Multiple Myeloma 97Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 96Lymphoma, Large-Cell, Anaplastic 96Mycosis Fungoides 90Sezary Syndrome 87Waldenstrom Macroglobulinemia 84Immunoblastic Lymphadenopathy 73Neoplasms 60Myelodysplastic Syndromes 59Blast Crisis 57Intraocular Lymphoma 49Hematologic Neoplasms 46Congenital Abnormalities 45Myeloproliferative Disorders 44Dendritic Cell Sarcoma, Interdigitating 44Leukemia, Myelomonocytic, Chronic 42

Interventions

entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Brain Stem Neoplasms × Lymphoid × Clear all
NCT02780804 2023-10-17

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
21 enrolled 15 charts
CNSLymphoid

Lymphoma, Pinealoma, Central Nervous System Neoplasms, Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡